Low credibility URL sharing on Twitter during reporting linking rare blood clots with the Oxford/AstraZeneca COVID-19 vaccine

Author:

Hobbs AliORCID,Aldosery Aisha,Kostkova Patty

Abstract

The COVID-19 pandemic was accompanied by an “infodemic” of misinformation. Misleading narratives around the virus, its origin, and treatments have had serious implications for public health. In March 2021, concerns were raised about links between the Oxford/AstraZeneca (AZ) COVID-19 vaccine and recipients developing blood clots. This paper aims to identify whether this prompted any reaction in the diffusion of low-credibility COVID-19-relate information on Twitter. Twitter’s application programming interface was used to collect data containing COVID-19-related keywords between 4th and 25th March 2021, a period centred on the peak of new coverage linking rare blood clots with the AZ vaccine. We analysed and visualised the data using temporal analysis and social network analysis tools. We subsequently analysed the data to determine the most influential users and domains in the propagation of low-credibility information about COVID-19 and the AZ vaccine. This research presents evidence that the peak of news coverage linking rare blood clots with the AZ vaccine correlated with an increased volume and proportion of low-credibility AZ-related content propagated on Twitter. However, no equivalent changes to the volume, propagation, or network structure for the full dataset of COVID-19-related information or misinformation were observed. The research identified RT.com as the most prolific creator of low-credibility COVID-19-related content. It also highlighted the crucial role of self-promotion in the successful propagation of low-credibility content on Twitter. The findings suggest that the simple approach adopted within the research to identify the most popular and influential sources of low-credibility content presents a valuable opportunity for public health authorities and social media platforms to develop bespoke strategies to counter the propagation of misinformation in the aftermath of a breaking news event.

Funder

Natural Environment Research Council

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference27 articles.

1. WHO. Coronavirus disease (COVID-19) pandemic. [Online].; 2023 [cited 2023 October 19. https://www.who.int/europe/emergencies/situations/covid-19.

2. WHO. Managing the COVID-19 infodemic: Promoting healthy behaviours and mitigating the harm from misinformation and disinformation. Joint statement by WHO, UN, UNICEF, UNDP, UNESCO, UNAIDS, ITU, UN Global Pulse, and IFRC. [Online].; 2020 [cited 2022 March 05. https://www.who.int/news/item/23-09-2020-managing-the-covid-19-infodemic-promoting-healthy-behaviours-and-mitigating-the-harm-from-misinformation-and-disinformation.

3. Susceptibility to misinformation about COVID-19 around the world;J Roozenbeek;R. Soc. Open Sci,2020

4. EMA. European Medicines Agency. [Online].; 2021 [cited 2021 September 17. https://www.ema.europa.eu/en/news/covid-19-vaccine-astrazeneca-prac-investigating-cases-thromboembolic-events-vaccines-benefits.

5. Comerford DA, Olivarius O, Bell D, Dawson A, Brown T, McGregor L, et al. Did negative news regarding the Oxford AstraZeneca Vaccine end in vaccine hesitancy? A repeated corss-section event study from the UK. ResearchSquare. 2021.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3